newsfilter
← Latest News
GlobeNewswire·

Kineta Announces Restructuring and Exploration of Strategic Alternatives

KA

SEATTLE, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (NASDAQ:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance,